Evidence map›Paper›PMID 33408019›Full record

SynthesisInternational journal of antimicrobial agents2021

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.

Matthieu Million, Yanis Roussel, Philippe Gautret, Didier Raoult

Open access · greenAbstract readLetterMeta-Analysis
In one paragraph

Synthesis in International journal of antimicrobial agents, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.International journal of antimicrobial agents · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthieu MillionIHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Yanis RousselIHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Philippe GautretIHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, VITROME, Marseille, France.
Didier RaoultIHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France. Electronic address: Didier.raoult@gmail.com.
Méditerranée Infection Foundation · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentAnti-Bacterial AgentsAntimalarialsAntiviral AgentsAzithromycinClinical Trials as TopicCOVID-19COVID-19 TestingDrug CombinationsDrug RepositioningDrug SynergismHumansHydroxychloroquineNasopharynxReverse Transcriptase Polymerase Chain ReactionRNA, ViralAnti-Bacterial AgentsAntimalarialsAntiviral AgentsAzithromycinDrug CombinationsHydroxychloroquineRNA, Viral

Identifiers

PMID33408019
PMCPMC7779266
OpenAlexW3119497033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.